A German man remains in remission from HIV an incredible six years after he received a stem cell transplant to treat an ...

People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...

A handful of people with HIV have been cured after receiving HIV-resistant stem cells – but a man who received non-resistant ...

A man living with HIV has been declared AIDS-free after receiving a stem cell transplant to treat blood cancer. He becomes the seventh person in the world to be declared HIV-free ...

Just as life is ever-evolving, so is the HIV treatment landscape. Thanks to decades of therapeutic improvements, people with HIV are living longer, healthier lives, but additional treatment needs may ...

Pretreatment drug resistance (PDR) in patients with HIV varies by subtype, affecting antiretroviral therapy implementation and first-line treatment efficacy. In Hangzhou, 8.4% of newly diagnosed HIV ...

A trial of lenacapavir showed 100% protection against HIV infection. But cuts to foreign aid and criticism over its pricing put the brakes on a worldwide rollout. Elna Schütz asks if we’re now seeing ...

GSK's antiretroviral HIV medicine Tivicay (dolutegravir) has been recommended by the World Health Organization (WHO) since 2018 as a preferred treatment for the virus. Now, the same agency is flagging ...

WHO report highlights high levels of HIV viral load suppression in populations undergoing dolutegravir-containing antiretroviral therapy. The lack of routine surveillance contributes to challenges in ...

Effective control of the spread of HIV depends on using the right antiretroviral drugs. In 2019, the World Health Organization recommended using the integrase inhibitor, dolutegravir (DTG), in first- ...

From left, Haifeng Chen, Fangping Cai, and Feng Gao have developed a sensitive test that can detect genetic mutations in HIV that cause drug resistance. Researchers are trying to tackle predicting a ...

(Reuters) -The World Health Organization (WHO) said on Tuesday resistance to GSK's HIV drug dolutegravir has exceeded levels observed during its trials, citing observational and survey data received ...